Cre8 EVO Stent Loses Sweet Spot in Diabetes at 2 Years: SUGA

Outcomes once deemed "almost too good to be true" disappeared with longer follow-up in an all-comer population of patients with diabetes undergoing revascularization.

Related Keywords

Madrid , Spain , New York , United States , Italy , Pablo Salinas , Roxana Mehran , Icahn School Of Medicine At Mount Sinai , Careggi University Hospital , Resolute Onyx , Hospital Clinico San Carlos , Transcatheter Cardiovascular Therapeutics , Carlo Di Mario , Icahn School , Mount Sinai , New York City , Medscape Cardiology , Stent , , Diabetes Mellitus , Acute Coronary Syndrome Acs , Cute Coronary Syndrome , Cs , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Hemoglobin A1c , Hemoglobin A1c Test , Glycated Hemoglobin , Glycosylated Hemoglobin , Ba1c , A1c , B1c , Lycohemoglobin , Hb , Diabe ,